Catalyst Wire Dossier Catalyst Wire Dossier

Investigational cholesterol-lowering medication

· Organon and Co
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational cholesterol-lowering medication, covering 2024-08-15 to 2024-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025) [Phase 3]

See pricing